Artificial Intelligence in Oncology: Practical Applications Across Clinical Care, Scholarship, and Translation
American Society of Clinical Oncology Educational Book · 2026-06 · 46 (3)
DOI: 10.1200/edbk-26-517280 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Society of Clinical Oncology Educational Book, 2026-06. Verfasst von Jasmin Hundal und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Oncology, Cleveland Clinic Foundation, Cleveland, OH. Hauptthemen laut MEDLINE: Artificial Intelligence, Medical Oncology, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben.
Abstract (Originalsprache)
Artificial intelligence (AI) is increasingly integrated into oncology across clinical care, research workflows, and translational implementation. This chapter provides a practical overview of these domains, emphasizing opportunities and limitations relevant to real-world oncology practice. In clinical care, AI applications include ambient documentation systems, decision support tools, and remote monitoring platforms. These technologies may reduce administrative burden, assist with evidence synthesis and guideline navigation, and enable longitudinal assessment of symptoms and functional status through wearable and patient-reported data. Emerging tools such as large language models also support patient communication through education, translation, and symptom triage. However, across these applications, performance remains dependent on data quality, validation, and appropriate clinical oversight. In research and scholarship, AI is increasingly used to support grant development, study design, literature review, and manuscript preparation. These tools may improve efficiency, enhance clarity, and assist in identifying research gaps or methodological approaches. At the same time, concerns regarding accuracy, hallucinated content, data privacy, and ethical responsibility require careful oversight. The responsibility for hypothesis generation, methodological rigor, and scientific integrity remains with the investigator. From a translational perspective, a persistent gap exists between model development and clinical deployment. Differences in data quality, infrastructure, and patient populations may limit generalizability, while workflow integration, clinician readiness, and bias mitigation remain critical challenges. Collectively, AI has the potential to enhance oncology care and research, but its impact depends on rigorous validation, equitable implementation, and sustained human oversight.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Hematology and Oncology, Cleveland Clinic Foundation, Cleveland, OH.
- Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH.
- Department of CNS-Radiation Oncology, MD Anderson, Houston, TX.
- Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL.
- Galter Health Sciences Library, Feinberg School of Medicine, Northwestern University, Chicago, IL.
ORCID-Profile: Jasmin Hundal
Zitieren
APA
Hundal, J., Veettil, A. A. V., Chung, C., & Hosseini, M. (2026). Artificial Intelligence in Oncology: Practical Applications Across Clinical Care, Scholarship, and Translation. American Society of Clinical Oncology Educational Book, 46(3). https://doi.org/10.1200/edbk-26-517280
Vancouver
Hundal J, Veettil AAV, Chung C, Hosseini M. Artificial Intelligence in Oncology: Practical Applications Across Clinical Care, Scholarship, and Translation. American Society of Clinical Oncology Educational Book. 2026;46(3). doi:10.1200/edbk-26-517280
BibTeX
@article{Hundal2026,
author = {Hundal, Jasmin and Veettil, Abhinav Anand Vayal and Chung, Caroline and Hosseini, Mohammad},
title = {Artificial Intelligence in Oncology: Practical Applications Across Clinical Care, Scholarship, and Translation},
journal = {American Society of Clinical Oncology Educational Book},
year = {2026},
volume = {46},
number = {3},
doi = {10.1200/edbk-26-517280}
}
EUVIMED